Back to search
FDAFDA · Food and drugs·Recall number D-0407-2026

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

Published March 25, 2026 · Recall initiated: March 5, 2026

Summary

FDA records drug Class II recall D-0407-2026, published March 25, 2026 and initiated March 5, 2026. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 107,136 vials; Lot: Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION
Manufacturer
Apotex Corp.
Distributor
U.S. Nationwide
Lot
Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1. recalled?

Yes. FDA published recall D-0407-2026 on March 25, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION.